Maurizio Zenoni
38Patents
5h-index
34Co-inventors
69Inventor score
Filing activity: Jul 7, 1993 → Mar 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6696412B1 | High purity lipopeptides, Lipopeptide micelles and processes for preparing same | Emerging Cross-Sectional Technologies | 22 | Expired |
| US8058238B2 | High purity lipopeptides | Emerging Cross-Sectional Technologies | 13 | Active |
| US8129342B2 | High purity lipopeptides | Emerging Cross-Sectional Technologies | 12 | Active |
| US5677443A | Bioavailable crystalline form of cefuroxime axetil | Chemistry; Metallurgy | 7 | Expired |
| US7071329B2 | Process for preparing cephalosporins with salified intermediate | Chemistry; Metallurgy | 5 | Expired |
| US8853357B2 | High purity lipopeptides | Emerging Cross-Sectional Technologies | 4 | Active |
| US8604164B2 | High purity lipopeptides | Emerging Cross-Sectional Technologies | 3 | Active |
| US8232392B2 | Process for preparing temozolomide | Chemistry; Metallurgy | 2 | Active |
| US6583291B2 | Process for obtaining compounds usable in the production of Cefotetan, and new compounds obtained thereby | Human Necessities | 1 | Expired |
| US8518988B2 | Polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester | Human Necessities | 1 | Active |
| US5654425A | Method for the acylation of the 7-amino group of the cephalosporanic ring | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5574153A | Oxime derivatives of cephalosporanic structure | Chemistry; Metallurgy | 1 | Expired |
| US7479556B2 | Process for producing Cefepime and cephalosporin analogues | Chemistry; Metallurgy | 1 | Active |
| US8049031B2 | Solid forms of fesoterodine fumarate | Chemistry; Metallurgy | 1 | Active |
| US8349900B2 | Bupropion hydrobromide polymorphs | Chemistry; Metallurgy | 1 | Active |
| US9358267B2 | High purity lipopeptides | Emerging Cross-Sectional Technologies | 0 | Active |
| US9266863B2 | Process for the synthesis of azacitidine and decitabine | Chemistry; Metallurgy | 0 | Active |
| US7964589B2 | Injectable sterile pharmaceutical formulation containing at least two active principles | Human Necessities | 0 | Active |
| US6255480A | Aminothiazole derivatives useful in the preparation of .beta.-lactam antibiotics | Chemistry; Metallurgy | 0 | Expired |
| US8445716B2 | Method for preparing fesoterodine and/or fesoterodine fumarate | Chemistry; Metallurgy | 0 | Active |
| US9096491B2 | Prodrug of an anti-inflammatory active ingredient | Chemistry; Metallurgy | 0 | Active |
| US9272982B2 | Method for preparing high-purity fesoterodine fumarate | Chemistry; Metallurgy | 0 | Active |
| US7728126B2 | Purification of beta-lactam products | Chemistry; Metallurgy | 0 | Active |
| US7605256B2 | Process for preparing sodium cefoxitin | Chemistry; Metallurgy | 0 | Active |
| US12129224B2 | Process for preparing {6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate having high purity | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.